Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study

• Egile Nagusiak: Castanedo-Cazares JP (Egilea), Lárraga-Piñones G (Egilea), Ehnis-Pérez A (Egilea), Fuentes-Ahumada C (Egilea), Oros-Ovalle C (Egilea), Smoller BR (Egilea), Torres-Alvarez B (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2013-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Juan Pablo Castanedo-Cazares,1 Gabryela Lárraga-Piñones,1 Adriana Ehnis-Pérez,1 Cornelia Fuentes-Ahumada,1 Cuauhtemoc Oros-Ovalle,2 Bruce R Smoller,3 Bertha Torres-Álvarez11Department of Dermatology, 2Department of Pathology, Hospital Central Dr Ignacio Mo...